We recently spoke with Kevin M. Crawford, head of clinical operations at Tenax Therapeutics, a specialty pharmaceutical company based in Morrisville, North Carolina, that focuses on identifying, developing, and commercializing products to address cardiovascular and pulmonary diseases. We wanted to share these excerpts from the conversation:
You’ve talked about the importance of telling your story. Can you expound on that?
At Tenax therapeutics, we're
As the coronavirus continues to spread and dominate the media, we are inundated with advice on what to do: How to boost our immunity, how to conduct business, how to wash our hands. If you are about to launch a clinical trial or initiate additional sites, consider this advice: press
We recently talked with Mike Keens, Chief Operating Officer at Firma Clinical Research, a clinical research service provider specializing in patient-focused trial designs, often with at-home visit support. We wanted to share these excerpts from the conversation:
What do you see as the biggest or most common challenges to preparation for,
Wecome to another issue of our interview series Conversations in Clinical Trial Readiness, by ArcheMedX.
Check back regularly for more.
We recently talked with Suzanne Kincaid, Chief Operating Officer at Aperio Clinical Outcomes, a CRO based in the Research Triangle Park area of North Carolina. We wanted to share these excerpts
When I first wrote this blog, I anticipated that 2020 would be a year that we could begin to advance the success of clinical trials for sponsors, CROs, and the patients who ultimately benefit with digital improvements to clinical trial training. Looking back, it's incredible how that idea escalated due